Saturday, October 18, 2025 10/18/2025

Therapeutic Targeting of Voltage Gated Sodium Channel Autoregulation

Award Number: R01HL169610
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2028

Group Awards By:

View Award Description

Therapeutic Targeting of Voltage Gated Sodium Channel Autoregulation - PROJECT SUMMARY Changes in ion channel biophysics and function due to mutation or disease-associated remodeling are frequently assessed in isolated cells; yet translation of these mechanistic changes for therapeutic target development is difficult and often fails due to the inherent lack of tissue-scale regulation that is missing in isolated cell experiments. Sodium channel gain-of-function is a critical example of this translational challenge, with well-identified ion channel biophysical dysfunction (i.e., gating); yet an estimated 16- 64% of congenital sodium channel gain-of-function patients present without an electrocardiographic phenotype. Our prior work demonstrated a proof-of-concept that modulation of ion concentrations in extracellular nanodomains can conceal or unmask this gain-of-function, and these dynamics are an inherently tissue-scale phenomenon, as the sodium channel enriched nanodomains adjacent to gap junctions at the intercalated disc. The current proposal seeks to demonstrate that this concept has significant potential for therapeutic target development and pre-clinical predictive assessment. Preliminary data demonstrate that extracellular sodium and potassium (through co-regulation by intercalated disc- localized potassium channels) can modulate the presentation of sodium channel gain-of-function in a manner that depends on intercalated disc structure. We propose computational simulations (novel structurally detailed tissue models) and experiments (isolated myocytes, ex vivo hearts, and in vivo genetically-modified mice and peptide treated guinea pigs) to test the hypothesis that sodium and potassium concentrations can serve as critical biomarkers that are co-factors for risk of electrophysiological dysfunction in the setting of sodium channel gain-of-function and concomitant perinexus expansion. While ion concentrations are already established biomarkers in clinical care, our proposal will test the hypothesis that so called ‘normal’ ranges may indeed be pathological in patients with sodium channel gain-of-function. Indeed, the standard collection of these biomarkers is an asset for future work that will seek to identify patients at greater risk for electrophysiological dysfunction. Upon successful completion of these aims, we will produce new mechanistic understanding of the manifestation of sodium channel gain-of-function, which will demonstrate a mechanistic equivalency between detection and therapy.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $698,336 )
2025	2025	VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY	300 TURNER ST NW	BLACKSBURG	VA	24060	MONTGOMERY	USA	Cardiovascular Diseases Research	001	2	7/16/2025	NON-COMPETING CONTINUATION	$69,834
2025	2025	VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY	300 TURNER ST NW	BLACKSBURG	VA	24060	MONTGOMERY	USA	Cardiovascular Diseases Research	000	2	4/23/2025	NON-COMPETING CONTINUATION	$628,502
														Subtotal = $698,336

Issue Date FY: 2024 ( Subtotal = $713,336 )
2024	2024	VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY	300 TURNER ST NW	BLACKSBURG	VA	24060	MONTGOMERY	USA	Cardiovascular Diseases Research	000	1	3/12/2024	NEW	$713,336
														Subtotal = $713,336

Grand Total All Awards = $1,411,672

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Therapeutic Targeting of Voltage Gated Sodium Channel Autoregulation

Award Number: R01HL169610

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer